Pharmaxis Ltd (AU:SNT) has released an update.
Syntara Limited has announced plans to issue 2,771,000 performance rights to its CEO as part of the company’s employee incentive scheme, with a focus on long-term rewards and retention. The rights will vest over two years and are subject to shareholder approval at the upcoming annual general meeting. Shares acquired upon exercise of these rights will be tradable with the Syntara Board’s prior approval.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
